374 related articles for article (PubMed ID: 11592857)
21. Protective effect of caffeic acid against beta-amyloid-induced neurotoxicity by the inhibition of calcium influx and tau phosphorylation.
Sul D; Kim HS; Lee D; Joo SS; Hwang KW; Park SY
Life Sci; 2009 Feb; 84(9-10):257-62. PubMed ID: 19101570
[TBL] [Abstract][Full Text] [Related]
22. Hibernation model of tau phosphorylation in hamsters: selective vulnerability of cholinergic basal forebrain neurons - implications for Alzheimer's disease.
Härtig W; Stieler J; Boerema AS; Wolf J; Schmidt U; Weissfuss J; Bullmann T; Strijkstra AM; Arendt T
Eur J Neurosci; 2007 Jan; 25(1):69-80. PubMed ID: 17241268
[TBL] [Abstract][Full Text] [Related]
23. The role of neurofibrillary tangles in Alzheimer disease.
Brion JP
Acta Neurol Belg; 1998 Jun; 98(2):165-74. PubMed ID: 9686275
[TBL] [Abstract][Full Text] [Related]
24. [The lesions of Alzheimer's disease: which therapeutic perspectives?].
Duyckaerts C; Perruchini C; Lebouvier T; Potier MC
Bull Acad Natl Med; 2008 Feb; 192(2):303-18; discussion 318-21. PubMed ID: 18819685
[TBL] [Abstract][Full Text] [Related]
25. Pathogenesis of Alzheimer's disease and dementia.
Bugiani O
Rev Neurol (Paris); 1999; 155 Suppl 4():S28-32. PubMed ID: 10637935
[TBL] [Abstract][Full Text] [Related]
26. Tau truncation during neurofibrillary tangle evolution in Alzheimer's disease.
Guillozet-Bongaarts AL; Garcia-Sierra F; Reynolds MR; Horowitz PM; Fu Y; Wang T; Cahill ME; Bigio EH; Berry RW; Binder LI
Neurobiol Aging; 2005 Jul; 26(7):1015-22. PubMed ID: 15748781
[TBL] [Abstract][Full Text] [Related]
27. Faulty regulation of tau phosphorylation by the reelin signal transduction pathway is a potential mechanism of pathogenesis and therapeutic target in Alzheimer's disease.
Deutsch SI; Rosse RB; Deutsch LH
Eur Neuropsychopharmacol; 2006 Dec; 16(8):547-51. PubMed ID: 16504486
[TBL] [Abstract][Full Text] [Related]
28. Changes of neurocalcin, a calcium-binding protein, in the brain of patients with Alzheimer's disease.
Shimohama S; Chachin M; Taniguchi T; Hidaka H; Kimura J
Brain Res; 1996 Apr; 716(1-2):233-6. PubMed ID: 8738246
[TBL] [Abstract][Full Text] [Related]
29. Alzheimer's disease plaques and tangles: cemeteries of a pyrrhic victory of the immune defence network against herpes simplex infection at the expense of complement and inflammation-mediated neuronal destruction.
Carter CJ
Neurochem Int; 2011 Feb; 58(3):301-20. PubMed ID: 21167244
[TBL] [Abstract][Full Text] [Related]
30. Brain site-specific gene expression analysis in Alzheimer's disease patients.
Yokota T; Mishra M; Akatsu H; Tani Y; Miyauchi T; Yamamoto T; Kosaka K; Nagai Y; Sawada T; Heese K
Eur J Clin Invest; 2006 Nov; 36(11):820-30. PubMed ID: 17032350
[TBL] [Abstract][Full Text] [Related]
31. Selective phosphorylation of adult tau isoforms in mature hippocampal neurons exposed to fibrillar A beta.
Ferreira A; Lu Q; Orecchio L; Kosik KS
Mol Cell Neurosci; 1997; 9(3):220-34. PubMed ID: 9245504
[TBL] [Abstract][Full Text] [Related]
32. Reversible translocation and activity-dependent localization of the calcium-myristoyl switch protein VILIP-1 to different membrane compartments in living hippocampal neurons.
Spilker C; Dresbach T; Braunewell KH
J Neurosci; 2002 Sep; 22(17):7331-9. PubMed ID: 12196554
[TBL] [Abstract][Full Text] [Related]
33. Immunoreactivity of the nuclear antigen p105 is associated with plaques and tangles in Alzheimer's disease.
Masliah E; Mallory M; Alford M; Hansen LA; Saitoh T
Lab Invest; 1993 Nov; 69(5):562-9. PubMed ID: 8246448
[TBL] [Abstract][Full Text] [Related]
34. Reversal by desferrioxamine of tau protein aggregates following two days of treatment in aluminum-induced neurofibrillary degeneration in rabbit: implications for clinical trials in Alzheimer's disease.
Savory J; Huang Y; Wills MR; Herman MM
Neurotoxicology; 1998 Apr; 19(2):209-14. PubMed ID: 9553957
[TBL] [Abstract][Full Text] [Related]
35. JNK plays a key role in tau hyperphosphorylation in Alzheimer's disease models.
Ploia C; Antoniou X; Sclip A; Grande V; Cardinetti D; Colombo A; Canu N; Benussi L; Ghidoni R; Forloni G; Borsello T
J Alzheimers Dis; 2011; 26(2):315-29. PubMed ID: 21628793
[TBL] [Abstract][Full Text] [Related]
36. The neuronal calcium-sensor protein VILIP modulates cyclic AMP accumulation in stably transfected C6 glioma cells: amino-terminal myristoylation determines functional activity.
Braunewell KH; Spilker C; Behnisch T; Gundelfinger ED
J Neurochem; 1997 May; 68(5):2129-39. PubMed ID: 9109541
[TBL] [Abstract][Full Text] [Related]
37. Calcium- and myristoyl-dependent subcellular localization of the neuronal calcium-binding protein VILIP in transfected PC12 cells.
Spilker C; Gundelfinger ED; Braunewell KH
Neurosci Lett; 1997 Apr; 225(2):126-8. PubMed ID: 9147390
[TBL] [Abstract][Full Text] [Related]
38. The visinin-like proteins VILIP-1 and VILIP-3 in Alzheimer's disease-old wine in new bottles.
Braunewell KH
Front Mol Neurosci; 2012 Jan; 5():20. PubMed ID: 22375104
[TBL] [Abstract][Full Text] [Related]
39. Immunocytochemical characterization of glial fibrillary tangles in Alzheimer's disease brain.
Nishimura M; Tomimoto H; Suenaga T; Namba Y; Ikeda K; Akiguchi I; Kimura J
Am J Pathol; 1995 May; 146(5):1052-8. PubMed ID: 7747799
[TBL] [Abstract][Full Text] [Related]
40. [Alzheimer's disease: cellular and molecular aspects].
Octave JN; Pierrot N
Bull Acad Natl Med; 2008 Feb; 192(2):323-31; discussion 331-2. PubMed ID: 18819686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
